Board of Directors
The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Executive Director Canadian Cancer Clinical Trials Network (3CTN)
Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Director of Research and Innovation, CreateIT Now @ Southlake Innovation Centre – The Research Institute at Southlake
Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)
Executive Director C-17 Council
Director-Clinical Trial Support Unit, Saskatchewan
Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University
Director, Clinical Research Administration, Ottawa Hospital Research Institute (OHRI)
Assistant Director, Institute of Cancer Research, CIHR
Director, Platform Operations – Alberta Innovates – Health Solutions
Project Manager, Marvelle Koffler Breast Centre Research Program